5-(ethylsulfonyl)-2-(naphthalen-2-yl)benzp[d]oxazole

[email protected]
5-(ethylsulfonyl)-2-(naphthalen-2-yl)benzp[d]oxazole
Trade Name
Orphan Indication Duchenne muscular dystrophy
USA Market Approval USA
USA Designation Date 2011-11-22 00:00:00
Sponsor Summit Corporation plc;91 Milton Park, Oxfordshire OX14 4RY;
Related Access Program
PTC Therapeutics – Duchenne Muscular Dystrophy Marathon Pharmaceuticals, LLC. – Duchenne muscular dystrophy PTC Therapeutics International Limited – Duchenne muscular dystrophy